Prognostic factors in primary breast carcinoma.
作者信息
Pinder S E, Ellis I O, Elston C W
机构信息
Department of Histopathology, City Hospital NHS Trust, Nottingham.
出版信息
J Clin Pathol. 1995 Nov;48(11):981-3. doi: 10.1136/jcp.48.11.981.
Abstract
摘要
相似文献
1
Prognostic factors in primary breast carcinoma.原发性乳腺癌的预后因素。
J Clin Pathol. 1995 Nov;48(11):981-3. doi: 10.1136/jcp.48.11.981.
2
Prognostic significance of pathologic findings in human breast carcinoma.人类乳腺癌病理结果的预后意义
Surg Gynecol Obstet. 1969 Aug;129(2):258-62.
3
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis.Ki-67 在原发性肿瘤中的预后相关性对远处转移诊断后的生存。
Breast Cancer Res Treat. 2013 Apr;138(3):899-908. doi: 10.1007/s10549-013-2460-y. Epub 2013 Mar 12.
4
[Various prognostic factors in breast cancer].
Ugeskr Laeger. 1977 Jun 6;139(23):1356-9.
5
[Prognostic factors in breast cancer].
Rev Prat. 1978 Mar 1;28(13):1039-40, 1043-4, 1047-8, passim.
6
["Prognostic factors" in breast cancer--1].
Z Arztl Fortbild (Jena). 1994 Feb;88(2):111-4.
7
Age at menarche as a prognostic factor in human breast cancer.
Eur J Cancer (1965). 1976 Sep;12(9):701-4. doi: 10.1016/0014-2964(76)90019-0.
8
[Cancer of the breast. II. Prognostic factors (our experience)].
Minerva Chir. 1989 Jun 30;44(12):1659-63.
9
[Prognostic parameters in metastatic breast cancers].
Pathol Biol (Paris). 1990 Oct;38(8):853-4.
10
[Clinicopathological features and prognostic factors of 22 cases of primary squamous cell carcinoma of the breast].22例原发性乳腺鳞状细胞癌的临床病理特征及预后因素
Zhonghua Zhong Liu Za Zhi. 2015 Apr;37(4):293-6.
引用本文的文献
1
Hi-C profiling in tissues reveals 3D chromatin-regulated breast tumor heterogeneity informing a looping-mediated therapeutic avenue.组织中的Hi-C分析揭示了3D染色质调节的乳腺肿瘤异质性，为环介导的治疗途径提供了信息。
Cell Rep. 2025 Apr 22;44(4):115450. doi: 10.1016/j.celrep.2025.115450. Epub 2025 Mar 18.
2
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study.PREDICT 2.1 结果的预先可获取性是否改变了 Oncotype DX 的检测实践？一项多中心前瞻性队列研究。
Curr Oncol. 2024 Feb 27;31(3):1278-1290. doi: 10.3390/curroncol31030096.
3
Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis.预测 Oncotype DX 复发评分：使用通过线性回归分析得出的病理生成方程。
Mod Pathol. 2013 May;26(5):658-64. doi: 10.1038/modpathol.2013.36. Epub 2013 Mar 15.
4
Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction.早期乳腺癌的他莫昔芬耐药性：组织标志物的统计建模以改善风险预测。
Br J Cancer. 2010 May 11;102(10):1503-10. doi: 10.1038/sj.bjc.6605627.
5
Profile of breast cancer in a group of women in a developing country in South Asia: is there a difference?南亚发展中国家一组妇女的乳腺癌特征：是否存在差异？
World J Surg. 2009 Mar;33(3):455-9. doi: 10.1007/s00268-008-9860-x.
6
Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localization.利用人类组织芯片和免疫组织化学技术进行核受体相互作用蛋白（NRIP）表达分析，证实其核定位。
J Exp Clin Cancer Res. 2008 Aug 2;27(1):25. doi: 10.1186/1756-9966-27-25.
7
Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status.雌激素和孕激素受体在乳腺癌患者中的预后作用：与年龄和淋巴结状态的关系。
J Clin Pathol. 1996 Nov;49(11):920-5. doi: 10.1136/jcp.49.11.920.
本文引用的文献
1
Immunohistochemical profile of invasive lobular carcinoma of the breast: predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive.乳腺浸润性小叶癌的免疫组化特征：波形蛋白和p53蛋白主要呈阴性，组织蛋白酶D和雌激素受体呈阳性。
Virchows Arch A Pathol Anat Histopathol. 1993;423(6):497-502. doi: 10.1007/BF01606541.
2
Histologic grading of breast carcinoma. A reproducibility study.乳腺癌的组织学分级。一项重复性研究。
Cancer. 1994 Jun 1;73(11):2765-70. doi: 10.1002/1097-0142(19940601)73:11<2765::aid-cncr2820731119>3.0.co;2-k.
3
Local recurrence after simple mastectomy.
Br J Surg. 1994 Mar;81(3):386-9. doi: 10.1002/bjs.1800810321.
4
Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up.乳腺癌的病理预后因素。III. 血管侵犯：一项长期随访的大型研究中与复发和生存的关系。
Histopathology. 1994 Jan;24(1):41-7. doi: 10.1111/j.1365-2559.1994.tb01269.x.
5
Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas.乳腺癌细针穿刺抽吸物细胞学分级的预后价值。
Lancet. 1994 Apr 16;343(8903):947-9. doi: 10.1016/s0140-6736(94)90066-3.
6
Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma.诺丁汉对浸润性导管癌的布卢姆和理查森组织学分级方案的观察者间再现性
Am J Clin Pathol. 1995 Feb;103(2):195-8. doi: 10.1093/ajcp/103.2.195.
7
Confirmation of a prognostic index in primary breast cancer.原发性乳腺癌预后指数的验证。
Br J Cancer. 1987 Oct;56(4):489-92. doi: 10.1038/bjc.1987.230.
8
Cytological grading of breast carcinoma--a feasible proposition?
Cytopathology. 1990;1(5):287-95. doi: 10.1111/j.1365-2303.1990.tb00362.x.
9
Prognosis and breast cancer. Recognition of lethal and favorable prognostic types.
Am J Surg Pathol. 1991 Apr;15(4):334-49. doi: 10.1097/00000478-199104000-00002.
10
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.乳腺癌的病理预后因素。I. 乳腺癌组织学分级的价值：一项长期随访大型研究的经验
Histopathology. 1991 Nov;19(5):403-10. doi: 10.1111/j.1365-2559.1991.tb00229.x.
Zotero 插件